Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Share-based Compensation (2016 - 2026)

Apyx Medical filings provide 15 years of Share-based Compensation readings, the most recent being $500000.0 for Q4 2025.

  • On a quarterly basis, Share-based Compensation fell 40.33% to $500000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $2.0 million, a 50.14% decrease, with the full-year FY2025 number at $2.0 million, down 50.14% from a year prior.
  • Share-based Compensation hit $500000.0 in Q4 2025 for Apyx Medical, down from $530000.0 in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $1.7 million in Q2 2022 to a low of $451000.0 in Q1 2025.
  • Median Share-based Compensation over the past 5 years was $1.2 million (2021), compared with a mean of $1.1 million.
  • Biggest five-year swings in Share-based Compensation: surged 42.91% in 2022 and later crashed 60.02% in 2025.
  • Apyx Medical's Share-based Compensation stood at $1.3 million in 2021, then increased by 22.37% to $1.6 million in 2022, then tumbled by 44.3% to $914000.0 in 2023, then decreased by 8.32% to $838000.0 in 2024, then plummeted by 40.33% to $500000.0 in 2025.
  • The last three reported values for Share-based Compensation were $500000.0 (Q4 2025), $530000.0 (Q3 2025), and $520000.0 (Q2 2025) per Business Quant data.